Detalles de la búsqueda
1.
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
N Engl J Med
; 383(12): 1117-1128, 2020 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32937045
2.
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
Am J Kidney Dis
; 81(3): 294-306.e1, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36058429
3.
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.
Nephrol Dial Transplant
; 38(12): 2733-2742, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463054
4.
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.
Kidney Int
; 101(2): 403-413, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560137
5.
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study.
Eur Respir J
; 42(6): 1484-94, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23722616
6.
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data.
Lupus Sci Med
; 10(1)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963777
7.
Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort.
Lupus Sci Med
; 9(1)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038160
8.
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study.
Clin J Am Soc Nephrol
; 17(11): 1620-1630, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302567
9.
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
Arthritis Rheumatol
; 71(6): 952-963, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666823
10.
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.
Lancet Respir Med
; 4(2): 107-15, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26803277
Resultados
1 -
10
de 10
1
Próxima >
>>